The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block
NCT ID: NCT03957772
Last Updated: 2021-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2020-01-01
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Extrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the exterior of the fascial sheath that surrounds the nerves
2. Intrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the interior of the fascial sheath that surrounds the nerves
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Distant Extrafascial Injection vs Subfascial Injection for Interscalene Block: Acute Pain Outcomes and Rates of Complications
NCT02074397
Single Versus Multiple Injections for Axillary Plexus Block
NCT03378323
Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block
NCT05389852
Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery
NCT02641613
Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block
NCT03138577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The first group - extrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the exterior of the fascial sheath that surrounds the nerves.
The second group - intrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the interior of the fascial sheath that surrounds the nerves.
All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %.
The primary outcome is the rate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound. Secondary outcomes are: rate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound, bedside spirometry before the supraclavicular block, 30 minutes after the block and 2 hours after surgery, rate of successful block 30 minutes after the block , duration of sensory and motor block, pain scores at rest and on movement at 24 h postoperatively, cumulative postoperative opioid consumption at 24 hours postoperatively and patient satisfaction with overall anesthetic management.
These outcomes are further defined in the section below.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extrafascial injection
Extrafascial injection of local anesthetic
Ultrasound guided supraclavicular plexus block with extrafascial injection of local anesthetic
Extrafascial injection
Extrafascial injection of local anaesthetic under ultrasound guidance
Intrafascial injection
Intrafascial injection of local anesthetic
Ultrasound guided supraclavicular plexus block with intrafascial injection of local anesthetic
Intrafascial injection
Intrafascial injection of local anaesthetic under ultrasound guidance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extrafascial injection
Extrafascial injection of local anaesthetic under ultrasound guidance
Intrafascial injection
Intrafascial injection of local anaesthetic under ultrasound guidance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status I-III
Exclusion Criteria
* ASA physical status IV
* Severe pre-existing lung disease
* Patient unwilling or unable to perform incentive spirometry
* Local anesthetic intolerance or allergy
* Neurological deficit or neuropathy of the arm
* Coagulopathy contraindicating locoregional anesthesia
* Malignancy or infection in the area above the clavicle
* Pregnancy
* Inability to understand the informed consent
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Hôpital du Valais
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sina Grape, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital du Valais
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital du Valais
Sion, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grape S, Kirkham K, Zemirline N, Bikfalvi A, Albrecht E. Impact of an extrafascial versus intrafascial injection for supraclavicular brachial plexus block on respiratory function: a randomized, controlled, double-blind trial. Reg Anesth Pain Med. 2022 Oct;47(10):604-609. doi: 10.1136/rapm-2022-103634. Epub 2022 Jul 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019 SUPRA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.